Dietary fructose as a metabolic risk factor

Area of Science:

• Microbiology
• Metabolic Diseases
• Nutritional Science

Background:

• Intestinal microbiota plays a crucial role in metabolic health.
• Diet, particularly sugar and fructose consumption, significantly influences microbiota.
• Increased fructose intake since the 1970s is a major risk factor for obesity and metabolic disturbances.

Purpose of the Study:

• To review the association between dietary fructose and metabolic diseases.
• To investigate the impact of fructose on insulin resistance, nonalcoholic fatty liver disease (NAFLD), and lipid metabolism.
• To explore the causal role of altered gut microbiota in metabolic disease and the potential of fecal microbial transplantation (FMT) as a therapeutic intervention.

Main Methods:

• Literature review focusing on dietary fructose intake and metabolic health.
• Analysis of studies examining the gut microbiota composition and function.
• Examination of fecal transplantation studies in human metabolic disease models.

Main Results:

• Dietary fructose is associated with insulin resistance, NAFLD, and altered lipid metabolism.
• Changes in gut microbiota composition and function are linked to increased fructose consumption.
• Fecal microbial transplantation shows potential in reversing fructose-induced metabolic phenotypes in some studies.

Conclusions:

• Dietary fructose significantly impacts the gut microbiota, contributing to metabolic dysfunction.
• Targeting the gut microbiota through interventions like fecal microbial transplantation may offer therapeutic strategies for fructose-induced metabolic diseases.